Evidence map›Paper›PMID 37721125›Full record

ArticleJournal of diabetes2024

Exercise ameliorating myocardial injury in type 2 diabetic rats by inhibiting excessive mitochondrial fission involving increased irisin expression and AMP-activated protein kinase phosphorylation.

Bin Wang, Chen Zhao, Yuanxin Wang, Xin Tian, Junjie Lin, Baishu Zhu, Yalan Zhou, Xin Zhang, Nan Li, Yu Sun and 2 more

Open access · goldAbstract read
In one paragraph

Article in Journal of diabetes, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Therapeutic Potential of Irisin in Neurodegenerative Diseases.International journal of molecular sciences · 2025
    Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Bin WangCollege of Physical Education, Yangzhou University, Yangzhou, China.ORCID https://orcid.org/0009-0000-0066-8084
Chen ZhaoCollege of Physical Education, Yangzhou University, Yangzhou, China.
Yuanxin WangCollege of Physical Education, Yangzhou University, Yangzhou, China.
Xin TianCollege of Physical Education, Yangzhou University, Yangzhou, China.
Junjie LinCollege of Physical Education, Yangzhou University, Yangzhou, China.
Baishu ZhuCollege of Physical Education, Yangzhou University, Yangzhou, China.
Yalan ZhouCollege of Physical Education, Yangzhou University, Yangzhou, China.
Xin ZhangCollege of Physical Education, Yangzhou University, Yangzhou, China.
Nan LiCollege of Physical Education, Yangzhou University, Yangzhou, China.
Yu SunCollege of Physical Education, Yangzhou University, Yangzhou, China.
Haocheng XuCollege of Physical Education, Yangzhou University, Yangzhou, China.
Renqing ZhaoCollege of Physical Education, Yangzhou University, Yangzhou, China.ORCID https://orcid.org/0000-0001-8901-9506
Yangzhou University · CN

Funding

Natural Science Foundation of Jiangsu Province BK20201435
6 · The paper itself

Abstract

purposeThough exercise generates beneficial effects on diabetes-associated cardiac damage, the underlying mechanism is largely unclear. Therefore, we prescribed a program of 8-week treadmill training for type 2 diabetes mellitus (T2DM) rats and determined the role of irisin signaling, via interacting with AMP-activated protein kinase (AMPK), in mediating the effects of exercise on myocardial injuries and mitochondrial fission.

methodsForty 8-week-old male Wistar rats were randomly divided into groups of control (Con), diabetes mellitus (DM), diabetes plus exercise (Ex), and diabetes plus exercise and Cyclo RGDyk (ExRg). Ex and ExRg rats received 8 weeks of treadmill running, and the rats in the ExRg group additionally were treated with a twice weekly injection of Cyclo RGDyk, an irisin receptor-αV/β5 antagonist. At the end of the experiment, murine blood samples and heart tissues were collected and analyzed with methods of ELISA, Western blot, real-time quantitative polymerase chain reaction, as well as immunofluorescence staining.

resultsExercise effectively mitigated T2DM-related hyperglycemia, hyperinsulinemia, lipid dysmetabolism, and inflammation, which could be diminished by Cyclo RGDyk treatment. Additionally, exercise alleviated T2DM-induced myocardial injury and excessive mitochondrial fission, whereas the beneficial effects were blocked by the administration of Cyclo RGDyk. T2DM significantly decreased serum irisin concentrations and fibronectin type III domain-containing protein 5 (FNDC5)/irisin gene and protein expression levels in the rat heart, whereas exercise could rescue T2DM-reduced FNDC5/irisin expression. Blocking irisin receptor signaling diminished the exercise-alleviated mitochondrial fission protein expression and elevated AMPK phosphorylation.

conclusionExercise is effective in mitigating diabetes-related insulin resistance, metabolic dysfunction, and inflammation. Irisin signaling engages in exercise-associated beneficial effects on myocardial injury and excessive mitochondrial fission in diabetes rats involving elevated AMPK phosphorylation.

Indexed as

Diabetes Mellitus, ExperimentalDiabetes Mellitus, Type 2AMP-Activated Protein KinasesAnimalsFibronectinsInflammationMaleMiceMitochondrial DynamicsPhosphorylationRatsRats, WistarAMP-Activated Protein KinasesFibronectinsFNDC5 protein, mouseFNDC5 protein, ratexerciseirisinmitochondrial fissionmyocardial injurytype 2 diabetes

Identifiers

PMID37721125
PMCPMC10809304
OpenAlexW4386818077

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.